Nejat ALTINTAŞ, Hikmet FIRAT

CPAP kullanımında yaşanan uyum problemleri ve çözüm yolları

CPAP tedavisi obstrüktif uyku apne sendromu tedavisinde ve obstrüktif uyku apne sendromuna bağlı komplikasyonları önlemede çok önemli bir yer tutar ve hastalar tarafından kullanılmadığı takdirde uyku apne teşhisinin de hiçbir anlamı kalmaz. Bu yazıda CPAP kullanan hastaların uyum konusunda karşılaştıkları sorunlar ve çözümler konusunda mesleki hayatlarında bu tür hastalarla sık karşılaşan hekimleri bilgilendirmek amaçlanmıştır. Bu amaçla, uyumda yaşanılan so- runlar; tedavi metodu, hastaların demografik özellikleri, hastalığın ciddiyeti, klostrofobi, hasta, aile, hekim, sağlık çalışan- ları alt ana başlıkları altında sunulmuştur.

Adherence problems during CPAP usage and solutions

CPAP treatment has a great importance in the treatment of obstructive sleep apnea syndrome and preventing complicati- ons due to obstructive sleep apnea syndrome however if it is not used by the patients, there is no point to diagnose obst- ructive sleep apnea syndrome. In this review, we wanted to inform the physicians who meet with this kind of patients of- ten in their daily practice about the compliance problems in patients who use CPAP and solution ways. That is why we presented compliance problems in subtitles such as treatment modalities, demographic properties of patients, severity of di- sease, clostrophobia, patient, physician, healthcare profesional.

PDF

___

1. Cintra FD, Poyares D, Guilleminault C, Carvalho AC, Tufik S, de Paola AAV. Cardiovascular comorbidities and obstructive sleep apnea. Arq Bras Cardiol 2006; 86: 399-407.
2. Fidan F, Unlu M, Sezer M, Kara Z. Relation between traffic ac- cidents and sleep apnea syndrome in truck drivers. Tuberk Toraks 2007; 55: 278-84.
3. Gander P, Scott G, Mihaere K, Scott H. Societal costs of obst- ructive sleep apnoea syndrome. N Z Med J 2010; 123: 13-23.
4. Bruin PFC de, Bagnato MDC. Cognitive impairment in obst- ructive sleep apnea syndrome. J Bras Pneumol 2010; 36(Suppl 2): 32-7.
5. Bayram NA, Diker E. Obstructive sleep apnea syndrome and cardiac arrhythmias. Turk Kardiyol Dern Ars 2008; 36: 44-50.
6. Ramar K, Guilleminault C. Cardiovascular complications of obstructive sleep apnea. Expert Rev Respir Med 2008; 2: 63- 74.
7. Moon IJ, Han DH, Kim JW, Rhee CS, Sung MW, Park JW, et al. Sleep magnetic resonance imaging as a new diagnostic met- hod in obstructive sleep apnea syndrome. Laryngoscope 2010; 120: 2546-54.
8. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pres- sure applied through the nares. The Lancet 1981; 1: 862-5.
9. Basner RC. Continuous positive airway pressure for obstructi- ve sleep apnea. N Engl J Med 2007; 356: 1751-8.
10. Anttalainen U, Liippo K, Saaresranta T. Diagnosis and initiati- on of nasal continuous positive airway pressure therapy for OSAS without a preceding sleep study? Sleep Breath 2011; 15: 791-7.
11. Antonescu-Turcu A, Parthasarathy S. CPAP and bi-level PAP therapy: new and established roles. Respir Care 2010; 55: 1216-29.
12. Taskin U, Yigit O, Acioglu E, Aricigil M, Toktas G, Guzelhan Y. Erectile dysfunction in severe sleep apnea patients and res- ponse to CPAP. Int J Impot Res 2010; 22: 134-9.
13. Bayram NA, Ciftci B, Keles T, Durmaz T, Turhan S, Bozkurt E, et al. Endothelial function in normotensive men with obstruc- tive sleep apnea before and 6 months after CPAP treatment. Sleep 2009; 32: 1257-63.
14. Durán-Cantolla J, Aizpuru F, Montserrat JM, Ballester E, Te- rán-Santos J, Aguirregomoscorta JI, et al. Continuous positive airway pressure as treatment for systemic hypertension in pe- ople with obstructive sleep apnoea: randomised controlled tri- al. BMJ 2010; 341: c5991.
15. Siccoli MM, Pepperell JCT, Kohler M, Craig SE, Davies RJO, Stradling JR. Effects of continuous positive airway pressure on quality of life in patients with moderate to severe obstruc- tive sleep apnea: data from a randomized controlled trial. Sle- ep 2008; 31: 1551-8.
16. Kohler M, Smith D, Tippett V, Stradling JR. Predictors of long- term compliance with continuous positive airway pressure. Thorax 2010; 65: 829-32.
17. Wolkove N, Baltzan M, Kamel H, Dabrusin R, Palayew M. Long-term compliance with continuous positive airway pres- sure in patients with obstructive sleep apnea. Can Respir J 2008; 15: 365-9.
18. Kakkar RK, Berry RB. Positive airway pressure treatment for obstructive sleep apnea. Chest 2007; 132: 1057-72.
19. Wenzel M, Kerl J, Dellweg D, Barchfeld T, Wenzel G, Köhler D. Expiratory pressure reduction (C-Flex Method) versus fix CPAP in the therapy for obstructive sleep apnoea. Pneumolo- gie 2007; 61: 692-5.
20.Javaheri S, Goetting MG, Khayat R, Wylie PE, Goodwin JL, Parthasarathy S. The performance of two automatic servo- ventilation devices in the treatment of central sleep apnea. Sle- ep 2011; 34: 1693-8.
21. Nilius G, Happel A, Domanski U, Ruhle KH. Pressure-relief continuous positive airway pressure vs. constant continuous positive airway pressure: a comparison of efficacy and comp- liance. Chest 2006; 130: 1018-24.
22. Dolan DC, Okonkwo R, Gfullner F, Hansbrough JR, Strobel RJ, Rosenthal L. Longitudinal comparison study of pressure relief (C-Flex) vs. CPAP in OSA patients. Sleep Breath 2009; 13: 73-7.
23. Leidag M, Hader C, Keller T, Meyer Y, Rasche K. Mask leakage in continuous positive airway pressure and C-Flex. J Physiol Pharmacol 2008; 59(Suppl 6): 401-6.
24.Aloia MS, Stanchina M, Arnedt JT, Malhotra A, Millman RP. Treatment adherence and outcomes in flexible vs. standard continuous positive airway pressure therapy. Chest 2005; 127: 2085-93.
25.Marshall NS, Neill AM, Campbell AJ. Randomised trial of compliance with flexible (C-Flex) and standard continuous positive airway pressure for severe obstructive sleep apnea. Sleep Breath 2008; 12: 393-6.
26.Bakker J, Campbell A, Neill A. Randomized controlled trial comparing flexible and continuous positive airway pressure delivery: effects on compliance, objective and subjective sle- epiness and vigilance. Sleep 2010; 33: 523-9.
27.Damjanovic D, Fluck A, Bremer H, Müller-Quernheim J, Idzko M, Sorichter S. Compliance in sleep apnoea therapy: influen- ce of home care support and pressure mode. Eur Respir J 2009; 33: 804-11.
28.Haniffa M, Lasserson TJ, Smith I. Interventions to improve compliance with continuous positive airway pressure for obst- ructive sleep apnoea. Cochrane Database Syst Rev 2004; (4): CD003531.
29.Hukins C. Comparative study of autotitrating and fixed-pres- sure CPAP in the home: a randomized, single-blind crossover trial. Sleep 2004; 27: 1512-7.
30. Galetke W, Anduleit N, Richter K, Stieglitz S, Randerath WJ. Comparison of automatic and continuous positive airway pressure in a night-by-night analysis: a randomized, crossover study. Respiration 2008; 75: 163-9.
31.McArdle N, Singh B, Murphy M, Gain KR, Maguire C, Mutch S, et al. Continuous positive airway pressure titration for obst ructive sleep apnoea: automatic versus manual titration. Tho- rax 2010; 65: 606-11.
32.Massie CA, Hart RW. Clinical outcomes related to interface type in patients with obstructive sleep apnea/hypopnea syndrome who are using continuous positive airway pressu- re. Chest 2003; 123: 1112-8.
33.Pepin JL, Leger P, Veale D, Langevin B, Robert D, Levy P. Side effects of nasal continuous positive airway pressure in sleep apnea syndrome. Study of 193 patients in two French sleep centers. Chest 1995; 107: 375-81.
34. Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc 2008; 5: 173-8.
35. Ryan S, Garvey JF, Swan V, Behan R, McNicholas WT. Nasal pillows as an alternative interface in patients with obstructive sleep apnoea syndrome initiating continuous positive airway pressure therapy. J Sleep Res 2011; 20: 367-73.
36. Khanna R, Kline LR. A prospective 8 week trial of nasal interfa- ces vs. a novel oral interface (Oracle) for treatment of obstructi- ve sleep apnea hypopnea syndrome. Sleep Med 2003; 4: 333-8.
37. Ryan S, Doherty LS, Nolan GM, McNicholas WT. Effects of he- ated humidification and topical steroids on compliance, nasal symptoms, and quality of life in patients with obstructive sle- ep apnea syndrome using nasal continuous positive airway pressure. J Clin Sleep Med 2009; 5: 422-7.
38. Rakotonanahary D, Pelletier-Fleury N, Gagnadoux F, Fleury B. Predictive factors for the need for additional humidification during nasal continuous positive airway pressure therapy. Chest 2001; 119: 460-5.
39.Richards GN, Cistulli PA, Ungar RG, Berthon-Jones M, Sulli- van CE. Mouth leak with nasal continuous positive airway pressure increases nasal airway resistance. Am J Respir Crit Care Med 1996; 154: 182-6.
40.Randerath WJ, Meier J, Genger H, Domanski U, Rühle KH. Ef- ficiency of cold passover and heated humidification under con- tinuous positive airway pressure. Eur Respir J 2002; 20: 183-6.
41. Massie CA, Hart RW, Peralez K, Richards GN. Effects of humi- dification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest 1999; 116: 403-8.
42. Neill AM, Wai HS, Bannan SPT, Beasley CR, Weatherall M, Campbell AJ. Humidified nasal continuous positive airway pressure in obstructive sleep apnoea. Eur Respir J 2003; 22: 258-62.
43. Kushida CA, Chediak A, Berry RB, Brown LK, Gozal D, Iber C, et al. Clinical guidelines for the manual titration of positive air- way pressure in patients with obstructive sleep apnea. J Clin Sleep Med 2008; 4: 157-71.
44. Campbell A, Neill A, Lory R. Ethnicity and socioeconomic sta- tus predict initial continuous positive airway pressure compli- ance in New Zealand adults with obstructive sleep apnoea. In- tern Med J 2012; 42: e95-101. doi:10.1111/j.1445-5994. 2010.02360.x
45. Scharf SM, Seiden L, DeMore J, Carter-Pokras O. Racial diffe- rences in clinical presentation of patients with sleep-disorde- red breathing. Sleep Breath 2004; 8: 173-83.
46.Joo MJ, Herdegen JJ. Sleep apnea in an urban public hospi- tal: assessment of severity and treatment adherence. J Clin Sleep Med 2007; 3: 285-8.
47. Wild MR, Engleman HM, Douglas NJ, Espie CA. Can psycho- logical factors help us to determine adherence to CPAP? A prospective study. Eur Respir J 2004; 24: 461-5.
48.Krieger J, Kurtz D, Petiau C, Sforza E, Trautmann D. Long-term compliance with CPAP therapy in obstructive sleep apnea pa- tients and in snorers. Sleep 1996; 19: 136-43.
49. Budhiraja R, Parthasarathy S, Drake CL, Roth T, Sharief I, Budhiraja P, et al. Early CPAP use identifies subsequent adhe- rence to CPAP therapy. Sleep 2007; 30: 320-4.
50. Villar I, Izuel M, Carrizo S, Vicente E, Marin JM. Medication ad- herence and persistence in severe obstructive sleep apnea. Sleep 2009; 32: 623-8.
51. Engleman HM, Martin SE, Douglas NJ. Compliance with CPAP therapy in patients with the sleep apnoea/hypopnoea syndrome. Thorax 1994; 49: 263-6.
52.Gay P, Weaver T, Loube D, Iber C, Positive Airway Pressure Task Force, Standards of Practice Committee, et al. Evaluation of positive airway pressure treatment for sleep related breat- hing disorders in adults. Sleep 2006; 29: 381-401.
53. Yetkin O, Kunter E, Gunen H. CPAP compliance in patients with obstructive sleep apnea syndrome. Sleep Breath 2008; 12: 365-7.
54. Sawyer AM, Gooneratne NS, Marcus CL, Ofer D, Richards KC, Weaver TE. A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Medicine Reviews 2011; 15: 343-56.
55. Rachman PDS, Taylor PDS. Analyses of claustrophobia. Journal of Anxiety Disorders 1993; 7: 281-91.
56. Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993; 147: 887-95.
57. Chasens ER. Claustrophobia and Adherence to CPAP Treat- ment. Western Journal of Nursing Research 2005; 27: 307-21.
58. Zonato AI, Bittencourt LRA, Martinho FL, Gregório LC, Tufik S. Upper airway surgery: the effect on nasal continuous positive airway pressure titration on obstructive sleep apnea patients. Eur Arch Otorhinolaryngol 2006; 263: 481-6.
59. Kalpaklioğlu AF, Kavut AB, Ekici M. Allergic and nonallergic rhinitis: the threat for obstructive sleep apnea. Ann Allergy Asthma Immunol 2009; 103: 20-5.
60. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A compre- hensive review. J Clin Pharm Ther 2001; 26: 331-42.
61. Cartwright R. Sleeping together: a pilot study of the effects of shared sleeping on adherence to CPAP treatment in obstructi ve sleep apnea. J Clin Sleep Med 2008; 4: 123-7.
62. Edinger JD, Radtke RA. Use of in vivo desensitization to treat a patient's claustrophobic response to nasal CPAP. Sleep 1993; 16: 678-80.
63. Poulet C, Veale D, Arnol N, Levy P, Pepin JL, Tyrrell J. Psychological variables as predictors of adherence to treatment by continuous positive airway pressure. Sleep Med 2009; 10: 993-9.
64. Simon-Tuval T, Reuveni H, Greenberg-Dotan S, Oksenberg A, Tal A, Tarasiuk A. Low socioeconomic status is a risk factor for CPAP acceptance among adult OSAS patients requiring treat- ment. Sleep 2009; 32: 545-52.
65. Platt AB, Field SH, Asch DA, Chen Z, Patel NP, Gupta R, et al. Neighborhood of residence is associated with daily adherence to CPAP therapy. Sleep 2009; 32: 799-806. 66. Engleman HM, Asgari-Jirhandeh N, McLeod AL, Ramsay CF, Deary IJ, Douglas NJ. Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest 1996; 109: 1470-6.
67.Richards D, Bartlett DJ, Wong K, Malouff J, Grunstein RR. Inc- reased adherence to CPAP with a group cognitive behavioral treatment intervention: a randomized trial. Sleep 2007; 30: 635-40.
68. Parish J. Quality of life in bed partners of patients with obst- ructive sleep apnea or hypopnea after treatment with continuous positive airway pressure. Chest 2003; 124: 942-7.
69. Brin YS, Reuveni H, Greenberg S, Tal A, Tarasiuk A. Determi- nants affecting initiation of continuous positive airway pres- sure treatment. Isr Med Assoc J 2005; 7: 13-8.
70. Baron KG, Smith TW, Czajkowski LA, Gunn HE, Jones CR. Re- lationship quality and CPAP adherence in patients with obst- ructive sleep apnea. Behav Sleep Med 2009; 7: 22-36.
71. Hoy CJ, Vennelle M, Kingshott RN, Engleman HM, Douglas NJ. Can intensive support improve continuous positive air- way pressure use in patients with the sleep apnea/hypopnea syndrome? Am J Respir Crit Care Med 1999; 159: 1096-100.
72.Weaver TE, Maislin G, Dinges DF, Younger J, Cantor C, McClos- key S, et al. Self-efficacy in sleep apnea: instrument develop- ment and patient perceptions of obstructive sleep apnea risk, treatment benefit, and volition to use continuous positive air- way pressure. Sleep 2003; 26: 727-32.
73. Lynch DJ, Birk TJ, Weaver MT, Gohara AF, Leighton RF, Rep- ka FJ, et al. Adherence to exercise interventions in the treat- ment of hypercholesterolemia. J Behav Med 1992; 15: 365-77.
74. Kulik JA, Carlino P. The effect of verbal commitment and tre- atment choice on medication compliance in a pediatric set- ting. J Behav Med 1987; 10: 367-76.
75. Shapiro GK, Shapiro CM. Factors that influence CPAP adhe- rence: an overview. Sleep Breath 2010; 14: 323-35.
76. Thompson SC, Nanni C, Schwankovsky L. Patient-oriented in- terventions to improve communication in a medical office vi- sit. Health Psychol 1990; 9: 390-404.
77. Smith CE, Dauz ER, Clements F, Puno FN, Cook D, Doolittle G, et al. Telehealth services to improve nonadherence: a placebo- controlled study. Telemed J E Health 2006; 12: 289-96.
78. Waldhorn RE, Wood K. Attended home titration of nasal con- tinuous positive airway pressure therapy for obstructive sleep apnea. Chest 1993; 104: 1707-10.
79. Stewart MA. Effective physician-patient communication and health outcomes: a review. CMAJ 1995; 152: 1423-33.